246 related articles for article (PubMed ID: 21656830)
1. Reactivation of embryonic nodal signaling is associated with tumor progression and promotes the growth of prostate cancer cells.
Lawrence MG; Margaryan NV; Loessner D; Collins A; Kerr KM; Turner M; Seftor EA; Stephens CR; Lai J; ; Postovit LM; Clements JA; Hendrix MJ
Prostate; 2011 Aug; 71(11):1198-209. PubMed ID: 21656830
[TBL] [Abstract][Full Text] [Related]
2. Differential role of Sloan-Kettering Institute (Ski) protein in Nodal and transforming growth factor-beta (TGF-β)-induced Smad signaling in prostate cancer cells.
Vo BT; Cody B; Cao Y; Khan SA
Carcinogenesis; 2012 Nov; 33(11):2054-64. PubMed ID: 22843506
[TBL] [Abstract][Full Text] [Related]
3. Expression of nodal and nodal receptors in prostate stem cells and prostate cancer cells: autocrine effects on cell proliferation and migration.
Vo BT; Khan SA
Prostate; 2011 Jul; 71(10):1084-96. PubMed ID: 21557273
[TBL] [Abstract][Full Text] [Related]
4. Transcriptional regulation of the androgen signaling pathway by the Wilms' tumor suppressor gene WT1.
Zaia A; Fraizer GC; Piantanelli L; Saunders GF
Anticancer Res; 2001; 21(1A):1-10. PubMed ID: 11299720
[TBL] [Abstract][Full Text] [Related]
5. TGF-beta signaling and androgen receptor status determine apoptotic cross-talk in human prostate cancer cells.
Zhu ML; Partin JV; Bruckheimer EM; Strup SE; Kyprianou N
Prostate; 2008 Feb; 68(3):287-95. PubMed ID: 18163430
[TBL] [Abstract][Full Text] [Related]
6. Androgen receptor and TGFbeta1/Smad signaling are mutually inhibitory in prostate cancer.
van der Poel HG
Eur Urol; 2005 Dec; 48(6):1051-8. PubMed ID: 16257107
[TBL] [Abstract][Full Text] [Related]
7. Growth hormone (GH) receptors in prostate cancer: gene expression in human tissues and cell lines and characterization, GH signaling and androgen receptor regulation in LNCaP cells.
Weiss-Messer E; Merom O; Adi A; Karry R; Bidosee M; Ber R; Kaploun A; Stein A; Barkey RJ
Mol Cell Endocrinol; 2004 May; 220(1-2):109-23. PubMed ID: 15196705
[TBL] [Abstract][Full Text] [Related]
8. Vav3 oncogene is overexpressed and regulates cell growth and androgen receptor activity in human prostate cancer.
Dong Z; Liu Y; Lu S; Wang A; Lee K; Wang LH; Revelo M; Lu S
Mol Endocrinol; 2006 Oct; 20(10):2315-25. PubMed ID: 16762975
[TBL] [Abstract][Full Text] [Related]
9. PC3, but not DU145, human prostate cancer cells retain the coregulators required for tumor suppressor ability of androgen receptor.
Litvinov IV; Antony L; Dalrymple SL; Becker R; Cheng L; Isaacs JT
Prostate; 2006 Sep; 66(12):1329-38. PubMed ID: 16835890
[TBL] [Abstract][Full Text] [Related]
10. Hormonal regulation of beta2-adrenergic receptor level in prostate cancer.
Ramberg H; Eide T; Krobert KA; Levy FO; Dizeyi N; Bjartell AS; Abrahamsson PA; Taskén KA
Prostate; 2008 Jul; 68(10):1133-42. PubMed ID: 18454446
[TBL] [Abstract][Full Text] [Related]
11. Tumor suppressor PAX6 functions as androgen receptor co-repressor to inhibit prostate cancer growth.
Shyr CR; Tsai MY; Yeh S; Kang HY; Chang YC; Wong PL; Huang CC; Huang KE; Chang C
Prostate; 2010 Feb; 70(2):190-9. PubMed ID: 19790232
[TBL] [Abstract][Full Text] [Related]
12. Hedgehog/Gli supports androgen signaling in androgen deprived and androgen independent prostate cancer cells.
Chen M; Feuerstein MA; Levina E; Baghel PS; Carkner RD; Tanner MJ; Shtutman M; Vacherot F; Terry S; de la Taille A; Buttyan R
Mol Cancer; 2010 Apr; 9():89. PubMed ID: 20420697
[TBL] [Abstract][Full Text] [Related]
13. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M
Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214
[TBL] [Abstract][Full Text] [Related]
14. Nodal signaling modulates the expression of Oct-4 via nuclear translocation of β-catenin in lung and prostate cancer cells.
Qi YF; Wu L; Li ZQ; Wu ML; Wang HF; Chan KY; Lu LL; Cai SH; Wang HS; Du J
Arch Biochem Biophys; 2016 Oct; 608():34-41. PubMed ID: 27592306
[TBL] [Abstract][Full Text] [Related]
15. Nodal signaling uses activin and transforming growth factor-beta receptor-regulated Smads.
Kumar A; Novoselov V; Celeste AJ; Wolfman NM; ten Dijke P; Kuehn MR
J Biol Chem; 2001 Jan; 276(1):656-61. PubMed ID: 11024047
[TBL] [Abstract][Full Text] [Related]
16. Regulation of FGF8 expression by the androgen receptor in human prostate cancer.
Gnanapragasam VJ; Robson CN; Neal DE; Leung HY
Oncogene; 2002 Aug; 21(33):5069-80. PubMed ID: 12140757
[TBL] [Abstract][Full Text] [Related]
17. Expression of nodal, lefty-a, and lefty-B in undifferentiated human embryonic stem cells requires activation of Smad2/3.
Besser D
J Biol Chem; 2004 Oct; 279(43):45076-84. PubMed ID: 15308665
[TBL] [Abstract][Full Text] [Related]
18. Expression profiles and functional associations of endogenous androgen receptor and caveolin-1 in prostate cancer cell lines.
Bennett NC; Hooper JD; Johnson DW; Gobe GC
Prostate; 2014 May; 74(5):478-87. PubMed ID: 24375805
[TBL] [Abstract][Full Text] [Related]
19. Tumor necrosis factor-alpha represses androgen sensitivity in the LNCaP prostate cancer cell line.
Mizokami A; Gotoh A; Yamada H; Keller ET; Matsumoto T
J Urol; 2000 Sep; 164(3 Pt 1):800-5. PubMed ID: 10953159
[TBL] [Abstract][Full Text] [Related]
20. Soluble factors derived from stroma activated androgen receptor phosphorylation in human prostate LNCaP cells: roles of ERK/MAP kinase.
Shigemura K; Isotani S; Wang R; Fujisawa M; Gotoh A; Marshall FF; Zhau HE; Chung LW
Prostate; 2009 Jun; 69(9):949-55. PubMed ID: 19274665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
